Clin2
NCT06929845Possibly a fitRecruiting

Organoid models for liver cancer study

Hepatocellular CarcinomaOrganoidsGut MicrobiotaTumor MicroenvironmentSystem Disorders, DigestiveSurgery

Part of Cancer, Digestive system clinical trials.

This study uses tumor samples to create lab-grown mini-livers (organoids) to better understand liver cancer. It may help researchers learn more about the disease and develop new treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a suspected or confirmed diagnosis of liver cancer (HCC)
  • You are scheduled for surgery to remove the tumor
  • You do not have any active viral infections
  • You are able and willing to sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06315868Recruiting
Breast cancer organoid study for tumor analysis

This study is testing a new way to understand your breast cancer by growing tiny tumor samples (called organoids) in the lab. It will help researchers learn more about your cancer type and could lead to better treatments.

Roma
NCT07690683Not yet recruiting
Gut health and immunotherapy for advanced liver cancer

This trial studies how the gut (your digestive system) affects how well immunotherapy works for advanced liver cancer. You'll have a colonoscopy (a test to look inside your bowel) and provide samples, which could help doctors improve treatment for you and others.

Roma
NCT06077591Recruiting
Genetic and organoid testing to guide cancer treatment

This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.

Hong Kong, N.T.
NCT05644743Not yet recruiting
Using tumor samples to predict chemotherapy response in bile duct cancer

This trial tests whether growing a patient's tumor cells in the lab can help doctors choose the best chemotherapy for intrahepatic cholangiocarcinoma, a type of bile duct cancer in the liver. The goal is to personalize treatment and improve outcomes.

NCT06905262Recruiting
Finding cancer targets for liver cancer immunotherapy

This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.

Naples
NCT06229522Recruiting
Organoids to personalize ovarian cancer treatment

This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.

Aviano, Pordenone

Hear when a new Hepatocellular Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.